from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: ACCENDRA HEALTH INC/VA/ quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
ACCENDRA HEALTH INC/VA/ Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $47,747,000, a 2025% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$47,747,000	+$45,500,000	+2025%	31 Dec 2025	10-K	20 Feb 2026	2025	FY
Q4 2024	$2,247,000	-$33,273,000	-94%	31 Dec 2024	10-K	20 Feb 2026	2025	FY
Q4 2023	$35,520,000	+$267,000	+0.76%	31 Dec 2023	10-K	28 Feb 2025	2024	FY
Q4 2022	$35,253,000	+$547,000	+1.6%	31 Dec 2022	10-K	20 Feb 2024	2023	FY
Q4 2021	$34,706,000	+$2,997,000	+9.5%	31 Dec 2021	10-K	28 Feb 2023	2022	FY
Q4 2020	$31,709,000	+$17,427,000	+122%	31 Dec 2020	10-K	23 Feb 2022	2021	FY
Q4 2019	$14,282,000	+$12,809,000	+870%	31 Dec 2019	10-K	24 Feb 2021	2020	FY
Q4 2018	$1,473,000	-$11,253,000	-88%	31 Dec 2018	10-K	04 Mar 2020	2019	FY
Q4 2017	$12,726,000	+$394,000	+3.2%	31 Dec 2017	10-K	06 Mar 2019	2018	FY
Q4 2016	$12,332,000	+$1,534,000	+14%	31 Dec 2016	10-K	23 Feb 2018	2017	FY
Q4 2015	$10,798,000	+$1,159,000	+12%	31 Dec 2015	10-K	17 Feb 2017	2016	FY
Q4 2014	$9,639,000	+$4,389,000	+84%	31 Dec 2014	10-K	25 Feb 2016	2015	FY
Q4 2013	$5,250,000	+$1,567,000	+43%	31 Dec 2013	10-K	23 Feb 2015	2014	FY
Q4 2012	$3,683,000	+$3,657,000	+14065%	31 Dec 2012	10-K	25 Feb 2014	2013	FY
Q4 2011	$26,000	+$26,000		31 Dec 2011	10-K	22 Feb 2013	2012	FY
Q4 2010	$0			31 Dec 2010	10-K	24 Feb 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.